Back
Day Range
$29.04
$30.44
52-Week Range
$4.30
$40.37
Volume
1,045,735
50D / 200D Avg
$26.28
/
$14.68
Prev Close
$28.87
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -13.0 | 0.2 |
| P/B | 4.5 | 3.0 |
| ROE % | -46.6 | 3.6 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 9.7 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$47.75
+59.7%
Low: $13.00
High: $62.00
Forward P/E
153.33
Forward EPS
$0.20
EPS Growth (est.)
+0.0%
Est. Revenue
149.82M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$6.31
-$1.43 – $15.11
|
683.66M | 1 |
| FY2029 |
$4.03
-$0.91 – $9.65
|
449.11M | 1 |
| FY2028 |
$2.04
$1.04 – $4.94
|
278.89M | 5 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-12 | -$0.51 | -$0.62 | -21.8% |
| 2025-11-10 | -$0.54 | -$0.54 | 0.0% |
| 2025-08-11 | -$0.48 | -$0.57 | -18.8% |
| 2025-05-13 | -$0.33 | -$0.53 | -60.6% |
| 2025-03-19 | -$0.31 | -$0.16 | +48.4% |
| 2024-11-13 | -$0.36 | -$0.38 | -5.6% |
| 2024-08-07 | -$0.36 | -$0.35 | +2.8% |
| 2024-05-13 | -$0.11 | -$0.31 | -181.8% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Debt/Equity of 0.07 — conservative balance sheet
Negative free cash flow of -72.72B
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-46.56%
ROIC-24.82%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.07
Current Ratio9.01
Interest Coverage-35.51
Valuation
P/E Ratio
-13.01
Forward P/E153.33
P/B Ratio4.47
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100.00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -105.04M |
| ROE | -46.56% | ROA | -29.51% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -72.72B |
| ROIC | -24.82% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.07 | Current Ratio | 9.01 |
| Interest Coverage | -35.51 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -13.01 | Forward P/E | 153.33 |
| P/B Ratio | 4.47 | P/S Ratio | N/A |
| PEG Ratio | -0.13 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 9.12 | Fwd Earnings Yield | 0.65% |
| FCF Yield | -5319.60% | ||
| Market Cap | 1.37B | Enterprise Value | 1.10B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 22.27M | 25.18M | 2.55M | 244,898.0 |
| Net Income | -105.04M | -40.47M | -22.29M | -29.02M | -20.02M |
| EPS (Diluted) | -2.26 | -1.15 | -0.83 | -1.18 | -0.87 |
| Gross Profit | 0.0 | -27.70M | -11.27M | -19.27M | 244,898.0 |
| Operating Income | -108.14M | -42.56M | -24.08M | -29.70M | -20.94M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 355.95M | 170.48M | 58.73M | 50.09M | 41.33M |
| Total Liabilities | 50.16M | 25.02M | 36.13M | 38.31M | 9.96M |
| Shareholders' Equity | 305.79M | 145.46M | 22.60M | 11.79M | 31.37M |
| Total Debt | 20.94M | 1.45M | 2.24M | 2.56M | 2.87M |
| Cash & Equivalents | 287.85M | 11.29M | 14.69M | 9.60M | 34.89M |
| Current Assets | 322.94M | 163.39M | 50.86M | 42.89M | 36.44M |
| Current Liabilities | 35.84M | 21.03M | 31.27M | 23.59M | 4.13M |